Viewing Study NCT00545766


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-01-21 @ 5:37 PM
Study NCT ID: NCT00545766
Status: COMPLETED
Last Update Posted: 2021-12-16
First Post: 2007-10-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
Sponsor: SCRI Development Innovations, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hormone Refractory View
None Prostate Cancer View
None Vinflunine View
None Salvage Chemotherapy View